Addex Therapeutics Ltd
Addex Therapeutics Ltd (ADXN) Revenue
Annual & quarterly revenue history · segment & region breakdown
ADXN · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsAddex Therapeutics Ltd trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Addex Therapeutics Ltd receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Addex Therapeutics Ltd reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Addex Therapeutics Ltd's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ADXN revenue · 4 questionsADXN's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Addex Therapeutics Ltd SEC filings · GAAP · Addex Therapeutics Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026